Unraveling the Molecular Biology of the Addicted Brain Towards Treatment Interventions

The ICN PhD Program is proud to announce that Dr. Yasmin Hurd will give a scientific seminar (plus a tutorial for PhD students) on july 5th at INMED (11.am).

Yasmin Hurd is the Ward-Coleman Chair of Translational Neuroscience and the Director of the Addiction Institute at Mount Sinai in New York. She investigates the neurobiology underlying addiction disorders and related psychiatric illnesses. A translational approach is used to examine molecular and neurochemical events in the human brain and comparable animal models in order to ascertain neurobiological correlates of behavior. A major focus of her research is directed to risk factors of addiction disorders including genetics as well as developmental exposure to drugs of abuse. The recent push to legalize recreational and medical marijuana has put the spotlight on Yasmin Hurd and her pioneering work on the transgenerational effects of cannabis on the developing brain.

Abstract :The talk will provide insights about molecular neurobiological markers in mesocorticolimbic brain regions that appear to be characteristic of addiction disorders, with particular focus on opioid use and the developmental effects of cannabis. A translational and multidisciplinary scientific approach is taken with molecular and pharmacological studies ranging from animal models and neurobiological investigations of the postmortem human brain to human clinical studies. The talk will also provide information about the potential of novel pharmacological targets of key biological marks that might function as therapeutic interventions.

Share the article